VPC

Vestal Point Capital Portfolio holdings

AUM $1.9B
1-Year Est. Return 12.28%
This Quarter Est. Return
1 Year Est. Return
-12.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$286M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1
+$125M
2
+$50.3M
3
+$41.8M
4
VERA icon
Vera Therapeutics
VERA
+$34.2M
5
NUVL icon
Nuvalent
NUVL
+$33.7M

Top Sells

1
+$120M
2
+$79.6M
3
+$57.6M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$56.5M
5
SLNO icon
Soleno Therapeutics
SLNO
+$47.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTYX icon
51
Ventyx Biosciences
VTYX
$414M
$2.3M 0.16%
2,000,000
ARCT icon
52
Arcturus Therapeutics
ARCT
$305M
$2.24M 0.16%
+211,790
PASG icon
53
Passage Bio
PASG
$22.7M
$2.15M 0.15%
305,000
FATE icon
54
Fate Therapeutics
FATE
$190M
$1.99M 0.14%
2,515,850
+50,850
ANRO icon
55
Alto Neuroscience
ANRO
$340M
$1.98M 0.14%
915,000
STRO icon
56
Sutro Biopharma
STRO
$89M
$1.69M 0.12%
2,600,000
+30,000
ENGN icon
57
enGene Holdings
ENGN
$423M
$1.66M 0.12%
370,000
ALEC icon
58
Alector
ALEC
$152M
$621K 0.04%
+504,540
ATRA icon
59
Atara Biotherapeutics
ATRA
$102M
$559K 0.04%
94,085
-30,915
TRAW icon
60
Traws Pharma
TRAW
$19.3M
$403K 0.03%
175,000
+100,000
MGNX icon
61
MacroGenics
MGNX
$116M
$356K 0.03%
280,000
TENX icon
62
Tenax Therapeutics
TENX
$33.7M
$350K 0.03%
53,439
-1,750
CNTA
63
Centessa Pharmaceuticals
CNTA
$3.24B
$214K 0.02%
+14,888
A icon
64
Agilent Technologies
A
$42B
– –
-75,000
ALLO icon
65
Allogene Therapeutics
ALLO
$266M
– –
-1,500,000
AZN icon
66
AstraZeneca
AZN
$258B
– –
-475,000
BHC icon
67
Bausch Health
BHC
$2.29B
– –
-250,000
BMRN icon
68
BioMarin Pharmaceuticals
BMRN
$10.5B
– –
-860,000
GLUE icon
69
Monte Rosa Therapeutics
GLUE
$688M
– –
-425,000
GSK icon
70
GSK
GSK
$86.9B
– –
-1,000,000
IONS icon
71
Ionis Pharmaceuticals
IONS
$11.3B
– –
-595,000
JAZZ icon
72
Jazz Pharmaceuticals
JAZZ
$8.4B
– –
-975,000
LEGN icon
73
Legend Biotech
LEGN
$5.88B
– –
-475,000
MDGL icon
74
Madrigal Pharmaceuticals
MDGL
$9.39B
– –
-95,000
MRK icon
75
Merck
MRK
$219B
– –
-800,000
1 2
3
4